Sign in

CIK 0001735438

  • Non-accelerated filer
  • Smaller reporting company

MeiraGTx Holdings plc

Sign in to watch
Ticker
MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
981448305
Phone
+1 646-860-7985
Business address
655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,375,392
in 3 filings, $1.4M under 10b5-1 plans

Net −$1,375,392. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-06 Indyk Martin Director Grant or award · Restricted Share Units +45,000 45,000
2024-06-05 Indyk Martin Director Exercise or conversion +20,000 35,000
2024-06-05 Indyk Martin Director Exercise or conversion · Restricted Share Units −20,000 0
2023-06-08 Indyk Martin Director Grant or award · Stock Option (right to buy) +20,000 20,000
2023-06-08 Indyk Martin Director Grant or award · Restricted Share Units +20,000 20,000
2023-06-07 Indyk Martin Director Exercise or conversion +15,000 15,000
2023-06-07 Indyk Martin Director Exercise or conversion · Restricted Share Units −15,000 0
2022-06-07 Indyk Martin Director Grant or award · Stock Option (right to buy) +15,000 15,000
2022-06-07 Indyk Martin Director Grant or award · Restricted Share Units +15,000 15,000
2021-06-10 Indyk Martin Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-06-10 Indyk Martin Director Grant or award · Restricted Share Units +15,000 15,000
2020-06-02 Indyk Martin Director Grant or award · Stock Option (right to buy) +25,000 25,000
2019-02-19 Indyk Martin Director Grant or award · Stock Option +50,000 50,000

Page 1 of 1 · 13 trades